Preparations of liposomal fluconazole and their in vitro antifungal activity

References

• BOHNEN, J., ODUMERU, J., KRESTA, A., and STIEK, P., 1991, Liposomal cefoxitin improves survival of experimental fecal peritonitis. 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, 1213,301.
   Google Scholar
• CLEMONS, K. V., HANSON, L. H., PERLMAN, A. M., and STEVENS, D. A., 1990, Efficacy of SCH39304 and fluconazole in a murine model of disseminated coccidioidomycosis. Antimicrobial Agents and Chemotherapy, 34, 928–930.
   PubMed Web of Science ®Google Scholar
• DROMER, F., BARBET, J., BOLARD, J., CHARREIRE, J., and YENI, P., 1990, Improvement of amphotoericin B activity during experimental cryptococcosis by incorporation into specific immmunoliposomes. Antimicrobial Agents and Chemotherapy, 34, 2055–2060.
   PubMed Web of Science ®Google Scholar
• FATTAL, E., RUJAS, J., YOUSSEF, M., COUVREUR, P., and ANDREMONT, A., 1991, Liposome entrapped ampicillin in the treatment of experimental murine listeriosis and sal-monellasis. Antimicrobial Agents and Chemotherapy, 35, 770–772.
   PubMed Web of Science ®Google Scholar
• FIERER, J., HATLEN, L., J. P., ESTRELLA, D., MIHALKO, P., and YOUNG, A. Y., 1990, Successful treatment using gentamicin liposomes of Salmonella dublin infections in mice. Antimicrobial Agents and Chemotherapy, 34, 343–348.
   Google Scholar
• HEYMAN, C., AUWERA, V. P., SCULIER, J. P., BRASSINNE, C., LADURON, C., HOLLAERT, C., and MEUNIER, F., 1990, 'In vitro evaluation of antifungal activity of amphotericin B entrapped into liposomes during storage for one year. Journal of Antimicrobial Chemotherapy, 25, 361–366.
   PubMed Web of Science ®Google Scholar
• HOPFER, R. L., MIccs, K., MEHTA, R., LOPEZ-BERESTEIN, G., FAINSTEIN, V., and JuLtANo, R. L., 1984, In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin B. Antimicrobial Agents and Chemotherapy, 25, 387–389.
   Google Scholar
• HOPFER, R. L., MEHTA, R., and LOPEZ-BERESTEIN, G., 1987, Synergistic antifungal activity and reduced toxicity of liposomal amphotericin B combined with gramicidin S or NF. Antimicrobial Agents and Chemotherapy, 31, 1978–1981.
   Google Scholar
• HOSPENTHAL, D. R., ROGERS, A. L., and BENEKE, E. S., 1989, Effect of attachment of anticandidal antibody to the surfaces of liposomes encapsulating amphotericin B in the treatment of murine candidiasis. Antimicrobial Agents and Chemotherapy, 33, 16–18.
   PubMed Web of Science ®Google Scholar
• JULLIEN, S., CONTREPOIS, A., SLIGH, J. E., DOMART, Y YEN, P., BRAJTBURG, J., MEDOFF, G., and BOLARD, J., 1989, Study of the effects of liposomal amphotericin B on Candida albicans, Cryptococcus neoformans, and erythrocytes by using small unilamellar vesicles prepared from saturated phospholipids. Antimicrobial Agents and Chemo-therapy, 33, 345–349.
   Google Scholar
• KLEMENS, S. R., CYNAMON, M. H., SWENSON, C. E., and GINSBERG, R. S., 1990, Liposome-encapsulated gentamicin therapy of Mycobacterium avium complex infection in beige mice. Antimicrobial Agents and Chemotherapy, 34, 967–970.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI, G. S., TRAVIS, S. J., RINALDI, G., and MEDOFF, G., 1990, In vitro and in vivo activities of SCH39304, fluconazole and amphotericin B against Histoplasma capsu-latum. Antimicrobial Agents and Chemotherapy, 34, 524–528.
   PubMed Web of Science ®Google Scholar
• LAZAR, J. D., and WILNER, K. D., 1990, Drug interactions with fluconazole. Reviews of Infectious Diseases, 12 (3), S327—S333.
   Google Scholar
• MEHTA, R. T., LOPEZ-BERNSTEIN, G., HOPFER, R., Mws, K., and JULIANO, R. L., 1984, Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells. Biochimica et Biophysica Acta, 770, 230–234.
   Google Scholar
• MEHTA, R. T., HOPFER, R. L., GUNNER, L. A., jULIANO, R. L., and LOPEZ-BERNSTEIN, G., 1987, Formulation, toxicity and antifungal activity in vitro of liposome encapsulated nystatin as therapeutic agent for systemic candidiasis. Antimicrobial Agents and Chemotherapy, 31, 1897–1900.
   Google Scholar
• MEHTA, R. T., MCQUEEN, T. J., KEYHANI, A., and LOPEZ-BERNSTEIN, G., 1991, Liposomal-Hamycin: reduced toxicity and improved antifungal efficacy in vitro and in vivo. American Association for Cancer Research Proceedings, 32, 431.
   Google Scholar
• MEZEI, M., and NUGENT, F. J., 1984, Method of encapsulating biologically active materials in multilamellar lipid vesicles. U.S. Patent 4,485, 054.
   Google Scholar
• PATTERSON, T. F., MINITER, P., and ANDRIOLE, V. T., 1990, Efficacy of fluconazole in experimental invasive aspergillosis. Reviews of Infectious Diseases, 12, 5281–5285.
   Google Scholar
• PERSHING, L. K., CORLETT, J., PONCELET, C., and LAM, S. Y., 1991, Comparison of topical antifungal bioavailability using in vivo and in vitro human skin models. Pharmaceutical Research, 8 (10), S–205.
   Google Scholar
• SCULIER, J. P., COUNE, A., MEUNIER, F., BRASSINNE, C., LADURON, C., HOLLAERT, C., COLLETTE, N., HEYMANS, C., and KLASTERSKY, J., 1988, Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections. European Journal of Cancer and Clinical Onocology, 24, 527–538.
   PubMed Web of Science ®Google Scholar
• SINGH, M., GROSE, T., FAULKNER, G., and MEZEI, M., 1990, Targeting of methotrexate containing liposomes with monoclonal antibody against human renal cancer. Cancer Research, 49, 3976–3984.
   Web of Science ®Google Scholar
• SINGH, M., GHOSE, T., MEZEI, M., and BELITSKY, P., 1991, Inhibition of human renal cancer by monoclonal antibody targeted methotrexate containg liposomes in an ascites tumor model. Cancer Letters, 56, 97–102.
   PubMed Web of Science ®Google Scholar
• SZOKA, F., and PAPAHADJOPOULOS, D., 1978, Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proceed-ings of the National Academy of Sciences USA, 75 (9), 4194–4198.
   PubMed Web of Science ®Google Scholar
• WAITZ, J. A., DOERN, G. V., FINEGOLD, S. M., GAVAN, T. L., HACKETT, J. L., JONES, R. N., JoaGENsEN, J. H., KING, J. R., MILLER, G. H., RELLER, L. B., THORNSBERRY, C., THRUPP, L. D., and ZABRANSKY, R. J., 1990, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, second edition. Approved Standard M7-A2. National Committee of Clinical and Laboratory Standards, Vil-lanova, PA, p. 12.
   Google Scholar
• WISEMAN, H., SMITH, C., ARNSTEIN, H. R., HALLIWELL, B., and CANON, M., 1991, The antioxidant action of ketoconazole and related azoles; comparisons with tamoxifen and cholesterol. Chemical—Biological Interactions, 79 (2), 229–243.
   PubMed Web of Science ®Google Scholar
• WITT, M. D., and BAYER, A. S., 1991, Comparison of fluconazole and amphotericin B for prevention and treatment of experimental candida endocarditis. Antimicrobial Agents and Chemotherapy, 35 (12), 2481–2485.
   PubMed Web of Science ®Google Scholar